vimarsana.com

Page 16 - பல்கலைக்கழகம் ஆஃப் டெக்சாஸ் ம்ட் ஆண்டர்சன் புற்றுநோய் மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Senti Bio Adds Prominent Scientific and Industry Leaders to its Scientific Advisory Board

Katalin Karikó and Drew Weissman Awarded Horwitz Prize for Pioneering Research on Covid Vaccines

FDA Approves Merck s Hypoxia-Inducible Factor-2 Alpha Inhibitor WELIREG for the Treatment of Patients With Certain Types of Von Hippel-Lindau Disease-Associated Tumors

WELIREG Approved for Adult Patients With VHL Disease Who Require Therapy for Associated Renal Cell Carcinoma, Central Nervous System Hemangioblastomas, or Pancreatic Neuroendocrine Tumors, Not Requiring Immediate Surgery WELIREG Expands Merck’s Oncology Portfolio as the First and Only Systemic Therapy Approved for These Patients With VHL Disease Merck known as MSD outside the United States and Canada, today .

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.